These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Author: Huang SM, Lu KT, Wang YC.
    Journal: Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599.
    Abstract:
    BACKGROUND: 3-Indole inhibits lung cancer growth by apoptosis. Here, the growth inhibition mechanism besides apoptosis was further characterized. MATERIALS AND METHODS: The Comet assay was used to examine 3-indole-induced DNA damage. Cell cycle distribution and protein expression were analyzed using flow cytometry, Western blotting and immunohistochemistry in cell and animal models. RESULTS: 3-Indole induced dose-dependent DNA damage, which was reversed by reactive oxygen species (ROS) inhibitor in lung cancer cells. Cell cycle G₁ arrest was observed in the 3-indole-treated cells. DNA damage-responsive proteins involved in the ataxia telangiectasia mutated/ataxia telangiectasia and Rad3-related (ATM/ATR) pathway and G₁ regulation proteins such as p21 and SMA- and MAD-related protein 3 (SMAD3) were induced in the cell models. The altered expression of ATM, ATR, checkpoint kinase 2 (CHK2), and cell division cycle 25 homolog A (CDC25A) were confirmed in xenograft models. Importantly, the 3-indole-induced ATM/ATR and transforming growth factor (TGF)-β/SMAD pathways were attenuated by ROS inhibitor. CONCLUSION: 3-Indole causes DNA damage and triggers ATM/ATR and SMAD3 signaling pathways to arrest lung cancer cells at the G₁-phase.
    [Abstract] [Full Text] [Related] [New Search]